Program News
News and stories about members of the UNC Lineberger Molecular Therapeutics Research Program
-
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.
-
Yeh, Johnson awarded five-year, $3.2 million research grant from NCI
The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype will help patients match to more effective first-line therapies.
-
How medical advances are improving glioblastoma care
Neuro-oncologist Soma Sengupta, MD, PhD, discusses glioblastoma symptoms, standard treatment and clinical trials.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
-
Inspired research: A conversation with Kirsten Bryant, PhD
Kirsten Bryant, PhD, shares what motivates her in the lab, how mentorship and advocacy have fueled her passion for pancreatic cancer research, and why she’s encouraged by progress made in the past decade.
-
Poor oral health could lessen survival from head and neck cancer
An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer.
-
NCI awards Pecot $1.8 million lung cancer research grant
The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
RNA discoveries drive oncologist’s next chapter
Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Lung Cancer Initiative awards Pecot $100,000 grant
The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.
-
Devising a smarter way to treat brain tumors
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
-
Getting to the heart of chemotherapeutic cardiotoxicity
Brian Jensen, MD, sees cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.
-
Lindsey James: Building a career, one molecule at a time
Lindsey James, PhD, is well-suited to the collaborative relationship between UNC Lineberger and UNC Eshelman School of Pharmacy, taking her interests in medicinal chemistry and epigenetics and working with cancer center physicians and researchers to make strides into cancer care and treatment.
-
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.